Inhibitory-&#954;B Kinase (IKK) &#945; and Nuclear Factor-&#954;B (NF&#954;B)-Inducing Kinase (NIK) as Anti-Cancer Drug Targets.

Paul, Andrew; Edwards, Joanne; Pepper, Christopher; Mackay, Simon

Inhibitory-κB Kinase (IKK) α and Nuclear Factor-κB (NFκB)-Inducing Kinase (NIK) as Anti-Cancer Drug Targets.

Paul, Andrew; Edwards, Joanne; Pepper, Christopher; Mackay, Simon.

Afiliação

Paul A; Strathclyde Institute of Pharmacy and Biomedical Sciences, 161 Cathedral Street, University of Strathclyde, Glasgow G4 0NR, UK. a.paul@strath.ac.uk.
Edwards J; Institute of Cancer Sciences, University of Glasgow, Garscube Estate, Switchback Road, Bearsden, Glasgow G61 1QH, UK. simon.mackay@strath.ac.uk.
Pepper C; Brighton and Sussex Medical School, University of Sussex, Brighton BN1 9PX, UK. Joanne.Edwards@glasgow.ac.uk.
Mackay S; Strathclyde Institute of Pharmacy and Biomedical Sciences, 161 Cathedral Street, University of Strathclyde, Glasgow G4 0NR, UK. simon.mackay@strath.ac.uk.

Cells ; 7(10)2018 Oct 20.

Article em En | MEDLINE | ID: mdl-30347849

Palavras-chave

NF-κB-inducing kinase (NIK); Nuclear Factor-κB (NF-κB); cancer; inflammation; inhibitory-κB kinase (IKK) α; small molecule kinase inhibitor

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Cells Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google